The diagnosis goes on for genetic characterization of GIST, mutational analysis confirming the diagnosis, particularly in CD117/DOG1 negative cases and having a predictive role in terms of sensitivity to specific treatment. Here, KIT is linked to gastrointestinal stromal tumor.